Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical trial.

Related Keywords

Mali ,Kenya ,Bamako ,Jeanne Marrazzo ,Nih National Institute Of Allergy ,National Institute Of Allergy ,National Institutes Of Health ,University Of Sciences ,World Health Organization ,Vaccine Research Center ,National Institute ,National Institutes ,New England Journal ,World Health ,Research Center ,Intramural Research International Centers ,